Oxtriphylline
Generic Name: oxtriphylline
Manufactured by WATSON LABS. Dosage form: TABLET, DELAYED RELEASE. Route: ORAL. Active ingredients: OXTRIPHYLLINE (200MG). Application: ANDA087835.
Overview
Manufactured by WATSON LABS. Dosage form: TABLET, DELAYED RELEASE. Route: ORAL. Active ingredients: OXTRIPHYLLINE (200MG). Application: ANDA087835.
Dosage
Available as tablet, delayed release for oral use.
Related Medications
Aletris Farinosa Root, Graphite, Chamaelirium Luteum Root, Pilocarpus Jaborandii Leaf, Lachesis Muta Venom, Anemone Pratensis Flowering Top, Sanguinaria Canadensis Root, And Lamium Album Flowering Top
aletris farinosa root, graphite, chamaelirium luteum root, pilocarpus jaborandii leaf, lachesis muta venom, anemone pratensis flowering top, sanguinaria canadensis root, and lamium album flowering top
For relief of minor menopausal symptoms. Application of this homeopathic remedy for the designated usage is exclusively based on homeopathic experience. With severe forms of this disease, a clinically proven therapy is indicated.
Avobenzone 3%, Homosalate 10%, Octisalate 4.5%, Octocrylene 8%
avobenzone 3%, homosalate 10%, octisalate 4.5%, octocrylene 8%
Purpose Sunscreen
Sennoside 25 Mg
sennoside 25 mg
Purpose Stimulant Laxative
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.